StockData
CDT Equity Inc. logo

CDT Equity Inc. (CDT) stock

CDTNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CDTTW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.38−0.02 (-5.84%)

Close on Nov 16, 2026Market cap $296.58KP/E –Yield –

CDT Equity operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

CDT Equity's operating cash flow for the twelve months ending Jun 30, 2026 was -$11.48M. For fiscal 2025 it was -$15.56M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$15.56M–
FY2024Dec 31, 2024-$9.68M–
FY2023Dec 31, 2023-$7.73M–
FY2022Dec 31, 2022-$2.27M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$544.00K–
Q1 FY2026Mar 31, 2026-$1.89M–
Q4 FY2025Dec 31, 2025-$4.64M–
Q3 FY2025Sep 30, 2025-$4.41M–
Q2 FY2025Jun 30, 2025-$2.58M–
Q1 FY2025Mar 31, 2025-$3.93M–
Q4 FY2024Dec 31, 2024-$3.81M–
Q3 FY2024Sep 30, 2024-$2.00M–
Q2 FY2024Jun 30, 2024-$1.51M–
Q1 FY2024Mar 31, 2024-$2.36M–
Q4 FY2023Dec 31, 2023-$4.80M–
Q3 FY2023Sep 30, 2023-$524.00K–
Q2 FY2023Jun 30, 2023-$428.00K–
Q1 FY2023Mar 31, 2023-$1.97M–
Q4 FY2022Dec 31, 2022-$880.00K–
Q3 FY2022Sep 30, 2022-$566.60K–
Q2 FY2022Jun 30, 2022-$126.92K–
Q1 FY2022Mar 31, 2022-$692.49K–

More CDT Equity figures

See a number that looks wrong?